Latest topics page 29
Topics ordered by most recent activity across all 71 subcategories.
1,535 topics · page 29 of 52
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Comparing two chromatograms from different laboratories, properly
Posting this under the heading it deserves: Comparing two chromatograms from different laboratories, properly Everything below is what sits behind that. I would like to understand what this number means…
|
+35 | 40 | 22k | 7mo |
|
Pooling trials with different estimands — what changed since
Pooling trials with different estimands — what changed since — setting out what I have, and where I think it stops being reliable. What changes if the standard account of Pooling trials with different…
|
+57 | 64 | 12k | 7mo |
|
Severe gastroparesis and why this class is a poor fit — one year on
Severe gastroparesis and why this class is a poor fit — one year on — setting out what I have, and where I think it stops being reliable. Asking about Severe gastroparesis directly, because I have read four…
|
+19 | 23 | 23k | 7mo |
|
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long version
On the subject in the title: Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long version Working notes rather than a conclusion. A narrow question about Tirzepatide in type 2…
|
+85 | 90 | 13k | 7mo |
|
Tirzepatide's shorter half-life and its one practical consequence
On the subject in the title: Tirzepatide's shorter half-life and its one practical consequence Working notes rather than a conclusion. Documentation question rather than a pharmacological one, but about this…
|
+18 | 29 | 20k | 8mo |
|
Documentation that materially improves an appeal's chances
Documentation that materially improves an appeal's chances — setting out what I have, and where I think it stops being reliable. An honest uncertainty about documentation rather than a disguised assertion. I…
|
+93 | 98 | 3.6k | 8mo |
|
Robustness: the parameters worth deliberately varying
Robustness: the parameters worth deliberately varying Writing it up because I had to work it out twice and would rather nobody else did. A narrow question about robustness, deliberately narrow, because the…
|
+53 | 57 | 664 | 8mo |
|
Second pass at: Asking a follow-up: new topic or new reply?
The question in the title: Second pass at: Asking a follow-up: new topic or new reply? I will give what I have already checked below so nobody repeats it. Posting a small dataset on Asking a follow-up. It is…
|
4 | 81 | 8mo | |
|
Water content on a certificate and why it changes the arithmetic — what changed since
On the subject in the title: Water content on a certificate and why it changes the arithmetic — what changed since Working notes rather than a conclusion. What changes if the standard account of Water content…
|
3 | 801 | 8mo | |
|
[2026 update] Why mass spectrometry cannot tell you about an epimer
Why mass spectrometry cannot tell you about an epimer — that is the question, and I have not found it answered plainly anywhere I have looked. Working through the identity arithmetic and I would like it…
|
2 | 1k | 8mo | |
|
Where the integrator drew the baseline, and how much it moved the number
Where the integrator drew the baseline, and how much it moved the number — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know what the first three…
|
+20 | 24 | 1.6k | 8mo |
|
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile — what changed since
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile — what changed since — setting out what I have, and where I think it stops being reliable. What changes if the standard…
|
+6 | 10 | 6.1k | 8mo |
|
How the vendor documentation pages are maintained, and by whom — what changed since
Asking directly, because I could not find a straight answer: How the vendor documentation pages are maintained, and by whom — what changed since What changes if the standard account of vendor documentation…
|
+98 | 104 | 3k | 8mo |
|
Cross-border purchase rules within the EU
On the subject in the title: Cross-border purchase rules within the EU Working notes rather than a conclusion. The question about cross-border purchase rules within that I actually want answered is the second…
|
+45 | 49 | 15k | 8mo |
|
Second pass at: A reconstituted vial's beyond-use date and the reasoning behind common figures
Second pass at: A reconstituted vial's beyond-use date and the reasoning behind common figures Writing it up because I had to work it out twice and would rather nobody else did. Something changed and I would…
|
+4 | 8 | 20k | 8mo |
|
What pooling buys you and what it destroys
The question in the title: What pooling buys you and what it destroys I will give what I have already checked below so nobody repeats it. The question about pooling buys that I actually want answered is the…
|
+74 | 83 | 6.6k | 8mo |
|
A preprint whose numbers changed substantially at publication — what changed since
On the subject in the title: A preprint whose numbers changed substantially at publication — what changed since Working notes rather than a conclusion. A preprint question rather than a question about the…
|
+3 | 7 | 125 | 8mo |
|
Journal club: how we handle discontinuation in obesity trials — what changed since
Journal club: how we handle discontinuation in obesity trials — what changed since — setting out what I have, and where I think it stops being reliable. Session topic: STEP 4 ( JAMA , 2021). Please read it…
|
+14 | 18 | 35k | 8mo |
|
Oral versus injectable exposure: comparing apples to a different fruit
Oral versus injectable exposure: comparing apples to a different fruit — setting out what I have, and where I think it stops being reliable. Something about oral versus injectable exposure does not reconcile…
|
+19 | 23 | 332 | 8mo |
|
Absolute versus relative contraindications
On the subject in the title: Absolute versus relative contraindications Working notes rather than a conclusion. Proposing that absolute versus relative contraindications deserves a maintained page rather than…
|
+4 | 8 | 23k | 8mo |
|
History of disordered eating and why it changes the conversation
History of disordered eating and why it changes the conversation Writing it up because I had to work it out twice and would rather nobody else did. What changes if the standard account of history of…
|
+20 | 24 | 30k | 8mo |
|
Gauge and length selection for subcutaneous injection
Gauge and length selection for subcutaneous injection Writing it up because I had to work it out twice and would rather nobody else did. A follow-up question about gauge and length selection that I did not…
|
+50 | 55 | 1.3k | 8mo |
|
Pharmaceutical compounding rules, summarised from primary sources — a second dataset
Posting this under the heading it deserves: Pharmaceutical compounding rules, summarised from primary sources — a second dataset Everything below is what sits behind that. Asking what a regulator's document…
|
+50 | 56 | 780 | 8mo |
|
Availability by country, dated, with primary sources
On the subject in the title: Availability by country, dated, with primary sources Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As…
|
+72 | 81 | 6.9k | 8mo |
|
Second pass at: Two scans six weeks apart on different machines: a cautionary tale
Second pass at: Two scans six weeks apart on different machines: a cautionary tale Writing it up because I had to work it out twice and would rather nobody else did. A question about measurement precision…
|
+1 | 5 | 34k | 8mo |
|
Follow-up: Retatrutide phase 2 in type 2 diabetes: the Lancet paper
Retatrutide phase 2 in type 2 diabetes: the Lancet paper Writing it up because I had to work it out twice and would rather nobody else did. A follow-up question about Retatrutide phase 2 in type that I did…
|
+1 | 5 | 31k | 8mo |
|
Second pass at: Programming during a large energy deficit
On the subject in the title: Second pass at: Programming during a large energy deficit Working notes rather than a conclusion. The question about Programming during a large energy that I actually want…
|
+94 | 100 | 1.2k | 8mo |
|
What a purity-only report leaves out
What a purity-only report leaves out — that is the question, and I have not found it answered plainly anywhere I have looked. Purity-only: setting out the arithmetic in full, because I have had to do it twice…
|
+92 | 105 | 4k | 8mo |
|
Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA
Posting this under the heading it deserves: Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA Everything below is what sits behind that. Reading back through what has been written here about…
|
+4 | 8 | 14k | 8mo |
|
Follow-up: Constipation management, with a dietitian's contribution
Constipation management, with a dietitian's contribution — setting out what I have, and where I think it stops being reliable. A follow-up question about Constipation management that I did not know to ask the…
|
+31 | 35 | 28k | 8mo |